Early disclosure of AD blood biomarker results increases diagnostic certainty and leads to earlier, more targeted clinical ...
New Delhi, Oct 12 (PTI) People who developed an early onset of Alzheimer's disease -- before turning 65 -- displayed symptoms and conditions different to those in late-onset Alzheimer's, accumulating ...
A new genetic study suggests GLP-1 drugs may be linked to lower odds of Alzheimer’s disease and certain types of stroke. Here ...
They differ from traditional risk factors associated with the late-onset form of the disease.
Ryan Libbey has opened up about his heartbreak over his grandparents' Alzheimer's diagnoses as he prepares to run the New ...
A metabolic byproduct of gut bacteria can damage the blood-brain barrier and drive the formation of Alzheimer's-related ...
Women with polycystic ovary syndrome, now known as polyendocrine metabolic ovarian syndrome, may have elevated risk for ...
Researchers in Montreal are taking part in an international clinical trial testing whether a drug can delay the onset of ...
Tauopathies are neurodegenerative diseases in which tau protein accumulates in twisted clumps. Alzheimer’s belongs to this group, but it also involves another protein, amyloid. In primary tauopathies, ...
Scientists have spent decades trying to get medicine across the blood-brain barrier. Two treatments for a rare genetic ...
UMBC is contributing to a multi-institution research project, funded by the Advanced Research  Projects Agency for Health ...
The introduction represents an important expansion of IGC Pharma's Artificial Intelligence and Alzheimer's disease strategy, ...